152 related articles for article (PubMed ID: 33488258)
1. Synthesis and molecular docking studies of quinoline derivatives as HIV non-nucleoside reverse transcriptase inhibitors.
Bhardwaj N; Choudhary D; Pathania A; Baranwal S; Kumar P
Turk J Chem; 2020; 44(6):1623-1641. PubMed ID: 33488258
[TBL] [Abstract][Full Text] [Related]
2. In silico design, synthesis and anti-HIV activity of quinoline derivatives as non-nucleoside reverse transcriptase inhibitors (NNRTIs).
Singh VK; Mishra R; Kumari P; Som A; Yadav AK; Ram NK; Kumar P; Schols D; Singh RK
Comput Biol Chem; 2022 Jun; 98():107675. PubMed ID: 35395595
[TBL] [Abstract][Full Text] [Related]
3. Exploring the hydrophobic channel of NNIBP leads to the discovery of novel piperidine-substituted thiophene[3,2-
Kang D; Feng D; Ginex T; Zou J; Wei F; Zhao T; Huang B; Sun Y; Desta S; De Clercq E; Pannecouque C; Zhan P; Liu X
Acta Pharm Sin B; 2020 May; 10(5):878-894. PubMed ID: 32528834
[TBL] [Abstract][Full Text] [Related]
4. Novel tight binding PETT, HEPT and DABO-based non-nucleoside inhibitors of HIV-1 reverse transcriptase.
D'Cruz OJ; Uckun FM
J Enzyme Inhib Med Chem; 2006 Aug; 21(4):329-50. PubMed ID: 17059165
[TBL] [Abstract][Full Text] [Related]
5. Novel broad-spectrum thiourea non-nucleoside inhibitors for the prevention of mucosal HIV transmission.
D'Cruz OJ; Uckun FM
Curr HIV Res; 2006 Jul; 4(3):329-45. PubMed ID: 16842085
[TBL] [Abstract][Full Text] [Related]
6. 2,4,5-Trisubstituted thiazole derivatives as HIV-1 NNRTIs effective on both wild-type and mutant HIV-1 reverse transcriptase: Optimization of the substitution of positions 4 and 5.
Xu Z; Guo J; Yang Y; Zhang M; Ba M; Li Z; Cao Y; He R; Yu M; Zhou H; Li X; Huang X; Guo Y; Guo C
Eur J Med Chem; 2016 Nov; 123():309-316. PubMed ID: 27484516
[TBL] [Abstract][Full Text] [Related]
7. Pyridine/Pyrimidine Substituted Imidazol-5-one Analogs as HIV-1 RT Inhibitors: Design, Synthesis, Docking and Molecular Dynamic Simulation Studies.
Mokale S; Lokwani D; Mujaheed A
Curr HIV Res; 2021; 19(6):535-547. PubMed ID: 34525923
[TBL] [Abstract][Full Text] [Related]
8. Structural Basis of 2-Phenylamino-4-phenoxyquinoline Derivatives as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors.
Makarasen A; Patnin S; Vijitphan P; Reukngam N; Khlaychan P; Kuno M; Intachote P; Saimanee B; Sengsai S; Techasakul S
Molecules; 2022 Jan; 27(2):. PubMed ID: 35056776
[TBL] [Abstract][Full Text] [Related]
9. De-novo design, synthesis and evaluation of novel 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives as HIV-1 reverse transcriptase inhibitors.
Chander S; Ashok P; Singh A; Murugesan S
Chem Cent J; 2015; 9():33. PubMed ID: 26075019
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis, and Evaluation of Thiophene[3,2-d]pyrimidine Derivatives as HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Significantly Improved Drug Resistance Profiles.
Kang D; Fang Z; Li Z; Huang B; Zhang H; Lu X; Xu H; Zhou Z; Ding X; Daelemans D; De Clercq E; Pannecouque C; Zhan P; Liu X
J Med Chem; 2016 Sep; 59(17):7991-8007. PubMed ID: 27541578
[TBL] [Abstract][Full Text] [Related]
11. Disubstituted pyrimidine-5-carboxamide derivatives as novel HIV-1 NNRTIs: Crystallographic overlay-based molecular design, synthesis, and biological evaluation.
Feng D; Lin H; Jiang L; Dai J; Zhang X; Zhou Z; Sun Y; Wang Z; Clercq E; Pannecouque C; Kang D; Zhan P; Liu X
Eur J Med Chem; 2023 Jan; 246():114957. PubMed ID: 36446205
[TBL] [Abstract][Full Text] [Related]
12. Application of Molecular Docking for the Development of Improved HIV-1 Reverse Transcriptase Inhibitors.
Soltani A; Hashemy SI; Avval FZ; Rafatpanah H; Rezaee SA; Griffith R; Mashkani B
Curr Comput Aided Drug Des; 2021; 17(4):538-549. PubMed ID: 32598265
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, molecular docking and biological evaluation of 2-(thiophen-2-yl)-1H-indoles as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
El-Hussieny M; El-Sayed NF; Ewies EF; Ibrahim NM; Mahran MRH; Fouad MA
Bioorg Chem; 2020 Jan; 95():103521. PubMed ID: 31884145
[TBL] [Abstract][Full Text] [Related]
14. Design of metronidazole derivatives and flavonoids as potential non-nucleoside reverse transcriptase inhibitors using combined ligand- and structure-based approaches.
Cutinho PF; Roy J; Anand A; Cheluvaraj R; Murahari M; Chimatapu HSV
J Biomol Struct Dyn; 2020 Apr; 38(6):1626-1648. PubMed ID: 31046644
[TBL] [Abstract][Full Text] [Related]
15. 2,4,5-Trisubstituted thiazole derivatives: a novel and potent class of non-nucleoside inhibitors of wild type and mutant HIV-1 reverse transcriptase.
Xu Z; Ba M; Zhou H; Cao Y; Tang C; Yang Y; He R; Liang Y; Zhang X; Li Z; Zhu L; Guo Y; Guo C
Eur J Med Chem; 2014 Oct; 85():27-42. PubMed ID: 25072874
[TBL] [Abstract][Full Text] [Related]
16. Molecular docking, design, synthesis and biological evaluation of novel 2,3-aryl-thiazolidin-4-ones as potent NNRTIs.
Geronikaki A; Petrou A; Kartsev V; Eleftheriou P; Boga R; Bartolo B; Crespan E; Franco G; Maga G
SAR QSAR Environ Res; 2019 Oct; 30(10):697-714. PubMed ID: 31542957
[TBL] [Abstract][Full Text] [Related]
17. Anti-HIV potential of diarylpyrimidine derivatives as non-nucleoside reverse transcriptase inhibitors: design, synthesis, docking, TOPKAT analysis and molecular dynamics simulations.
Singh VK; Srivastava R; Gupta PSS; Naaz F; Chaurasia H; Mishra R; Rana MK; Singh RK
J Biomol Struct Dyn; 2021 Apr; 39(7):2430-2446. PubMed ID: 32216610
[TBL] [Abstract][Full Text] [Related]
18. Identification of Boronate-Containing Diarylpyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors.
Feng D; Lin H; Jiang L; Wang Z; Sun Y; Zhou Z; Clercq E; Pannecouque C; Kang D; Zhan P; Liu X
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364360
[TBL] [Abstract][Full Text] [Related]
19. 3D-QSAR, molecular docking, and molecular dynamics analysis of novel biphenyl-substituted pyridone derivatives as potent HIV-1 NNRTIs.
Jiang H; Li Y; Wang Z; Li S; Wu T; Xiong F
J Biomol Struct Dyn; 2023 Nov; ():1-16. PubMed ID: 37909494
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and anti-HIV-1 activity of 1-aromatic methyl-substituted 3-(3,5-dimethylbenzyl)uracil and N-3,5-dimethylbenzyl-substituted urea derivatives.
Sakakibara N; Baba M; Okamoto M; Toyama M; Demizu Y; Misawa T; Kurihara M; Irie K; Kato Y; Maruyama T
Antivir Chem Chemother; 2015 Feb; 24(1):3-18. PubMed ID: 26149262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
